secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-08-11T20:10:17+00:00
Accession:  0001628280-26-055697
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics GC Alicia Olivo to step down; transition effective Sept 21, 2026
----------------------------------------------------------------------------

- Announced Aug 11, 2026: EVP, General Counsel & Business Development Alicia Olivo will cease as GC effective Sept 21, 2026.
- Olivo remains employee until Oct 2, 2026 for transition; separation payments per Section 5(b) of employment agreement.
- No successor named; CFO Abhishek Jain signed filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/0001628280-26-055697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/neo-20260807.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-055697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer